Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Therapeutics for Biodefense and Emerging Infectious Diseases
Henkel, Timothy
Venatorx Pharmaceuticals, Inc., Malvern, PA, United States
Search 5 grants from Timothy Henkel
Search grants from Venatorx Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Ctr for Integrative Studies of Aging: Addition, Opiate Peptides
Thrombolytic Agent From Rattlesnake Venom
STTR Phase I: Commercialization of Synthetic Metabolic Valves
Measurement and Computation of Electromagnetic Fields for Undergraduate Students
Recently added grants:
Metabolite modulation of Mtb regulators of cell wall biogenesis
Development of a Universal Influenza Vaccine Against Influenza A and B Viruses
Nutrient Uptake during Anthrax Disease
ECM/Integrin Tfh positioning cues for support of the germinal center response
Antibody therapy for pneumococcal disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272201600029C-3-0-1
Application #
9659267
Study Section
Project Start
2016-09-23
Project End
2020-01-12
Budget Start
Budget End
Support Year
Fiscal Year
2018
Total Cost
Indirect Cost
Institution
Name
Venatorx Pharmaceuticals, Inc.
Department
Type
DUNS #
962754037
City
Malvern
State
PA
Country
United States
Zip Code
19355
Comments
Be the first to comment on Timothy Henkel's grant